What the hell's going on?
Today was utter carnage, with the whole portfolio bar two shares red and ironically those two are RDT:Rosslyn Data and TRK:Torotrak which are both delinquent basket cases!
The combined portfolios lost £1,100 today, and yesterday was almost as bad so we're £1,782 down this week and £139 in the red overall. The buffer has been annihilated.
Never mind, at least my JLP:Jubilee Platinum shares got bedded into my ISA today.
I cocked up a little, as I also bedded the shares that count towards my trading account. It all got a bit messy trying to disentangle them, and I don't really want to have any trading shares in the ISA, so I wrote them off my trading account as a loss and will keep them in my ISA. Unfortunately it means the £500 won't now get liberated to go towards the Visa bill, but I think I'd rather keep the shares anyway.
So the impact of all this is that I made a whopping £34.87 (0.6%) from the sale in my share account seeing as the price has plummeted. I'd hoped bedding these would get me back over my 10% target but it hasn't happened.
I sold a total of 90,207 at 4.5125p and bought back 89,545 at 4.5325p. so I lost 662 shares worth £29.87 which is ok for the protection from tax.
The effect on the trading account was horrid. That resulted in a £84.42 loss and means my performance on that account is now -£22.85. I find myself laughing hysterically at what an utter disaster my attempt at short-term trading has been. So glad I'm doing it with a tiny percentage of the portfolio.
Today has made me very miserable. OPTI:Optibiotix dropped another 2p and is losing £1,571. KIBO:Kibo Mining dropped 0.25p and is losing £1,169.53 which means OPTI:Optibiotix re-gains the title of Nemesis Share. It also means I may just buy some more tomorrow as 67.5p is an absolute steal given the new cardio products are being launched next week. Tomorrow morning could be very interesting....
Wednesday, 3 May 2017
Tuesday, 2 May 2017
Week 90 Review
A rather traumatic week saw the combined portfolios end up with a difference between cost and value that was £351.29 better than last week. However, the cost reduced by £833.76 due to the £1,167 loss from the AFG:Aquatic Foods sale minus the £242.63 profit from bedding some AMYT:Amryt Pharma shares into my ISA and £100 I added from my current account. So in reality, the portfolio suffered a paper loss of £482.
Worst performer was RDT:Rosslyn Data which dropped 14% after announcing a placing at a significant discount to the current price. They also announced an open offer, which I have decided to accept, as I get 294 shares for just £13.23 with no commission. This will drop my average purchase price from 17.52p to 15.85p for hardly any money. I really don't know if this share will ever recover, but I'm happy to take a risk for such a small amount to increase the value of any recovery.
My other double-digit loser was KIBO:Kibo Mining which continues to disappoint, dropping 11% and taking the paper loss to £1,169.53.That demotes it to Nemesis Share as OPTI:Optiobiotix is losing a mere £1,147.06. Both of these were making big profits not long ago - when both were in a much less optimistic position than they are now. It really doesn't make sense!
The Share of the Week is the only double-digit riser this week, and it's my old favourite Star Share IQE:IQE, climbing 15% and now standing at £2,937.96 potential profit.I think there's a lot further for this one to go, although wouldn't be surprised if there's a pull back at some point - and I'll be ready to buy more if it does!
Still in overall profit, but the buffer has been obliterated.
The ISA and share portfolios look like this
The most complex weekly update ever! I've changed the way the formula works for defining sell value, as it usually takes off any increase in portfolio cost. With the portfolio cost dropping by £833 this week, it showed a rise in sell value which was plain wrong. Now, if the cost has gone down, then that figure isn't taken off the sell value difference. So there's been a drop of £516.15 this week, with most being deepening losses, as potential profits are up £59. There was a quarterly dividend from CMCL:Caledonia Mining of £7.94. Nice to have that regular income, I really should buy more! Profit from sales was hammered by the AFG:Aquatic Food disaster which drags this year's performance down by over £100 a month, and overall performance down by £48 a month. Pretty depressing, but at least I saved £900 from almost certain doom if I hadn't sold my shares.
Doesn't so much fly as plummet...
Here's the SIPP after week 74
Not bad. Potential profits up nicely by £234, but drops in OPTI:Optibiotix and JLP:Jubilee Platinum ate most of that up. Average monthly performance still way over target 10%, which is good as there's nothing I really want to sell in this portfolio - except WRES:W Resources which was a big mistake.
Still happy with this one
The trading account looks like this after week 40
Although an unmitigated disaster based on my expectations, a return of 5.4% isn't bad, if I ever recover the 13.1 paper loss on the portfolio, which I'm sure I will one day...
Urrrrg...
So this week I offloaded one of my two big howlers, with AFG:Aquatic Food biting the dust. My other big howler AFPO:African Potash is currently suspended and I'm not intending to sell as the transaction would cost me £6.38 with the returns not even covering the commission. At some point they will go bust, and my performance will be hit by another big loss, this time of £714. When it happens, I will certainly need to sell something for a similar profit else I risk sinking well below my 10% target for the ISA/shares accounts.
I don't think anything interesting will happen next week. It's a short week with bank holiday, no results or trading statements expected, and I'm quite relieved as there was too much excitement this week. I've decided to leave my bed & ISA order open for JLP:Jubilee Platinum, just to see how long it takes for Hargreaves Lansdown to actually do anything about it. I'm hoping I can rely on them to be sensible and make the transfer when there's a small spread and no volatility, else I'll be somewhat peeved. At current prices that will generate £296 profit from the sale, so should get my average performance back over the magic 10%.
Worst performer was RDT:Rosslyn Data which dropped 14% after announcing a placing at a significant discount to the current price. They also announced an open offer, which I have decided to accept, as I get 294 shares for just £13.23 with no commission. This will drop my average purchase price from 17.52p to 15.85p for hardly any money. I really don't know if this share will ever recover, but I'm happy to take a risk for such a small amount to increase the value of any recovery.
My other double-digit loser was KIBO:Kibo Mining which continues to disappoint, dropping 11% and taking the paper loss to £1,169.53.That demotes it to Nemesis Share as OPTI:Optiobiotix is losing a mere £1,147.06. Both of these were making big profits not long ago - when both were in a much less optimistic position than they are now. It really doesn't make sense!
The Share of the Week is the only double-digit riser this week, and it's my old favourite Star Share IQE:IQE, climbing 15% and now standing at £2,937.96 potential profit.I think there's a lot further for this one to go, although wouldn't be surprised if there's a pull back at some point - and I'll be ready to buy more if it does!
Still in overall profit, but the buffer has been obliterated.
The ISA and share portfolios look like this
| Weekly Change | |||
| Portfolio cost | £42,130.26 | -£833.76 | |
| Portfolio sell value (bid price - commission) | £41,149.71 | (-2.3%) | -£516.15 |
| Potential profits | £4,450.01 | +£59.98 | |
| Yr 2 Dividends | £365.04 | +£7.94 | |
| Yr 2 Profit from sales | £2,389.56 | -£925.23 | |
| Yr 2 Average monthly cash profit | £310.70 | -£115.83 | |
| Yr 2 Avg annual % of current portfolio cost | 8.8% | ||
| Total Dividends | £1,032.97 | +£7.94 | |
| Total Profit from sales | £6.229.82 | -£925.23 | |
| Average monthly cash profit | £345.34 | -£48.54 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 9.8% |
The most complex weekly update ever! I've changed the way the formula works for defining sell value, as it usually takes off any increase in portfolio cost. With the portfolio cost dropping by £833 this week, it showed a rise in sell value which was plain wrong. Now, if the cost has gone down, then that figure isn't taken off the sell value difference. So there's been a drop of £516.15 this week, with most being deepening losses, as potential profits are up £59. There was a quarterly dividend from CMCL:Caledonia Mining of £7.94. Nice to have that regular income, I really should buy more! Profit from sales was hammered by the AFG:Aquatic Food disaster which drags this year's performance down by over £100 a month, and overall performance down by £48 a month. Pretty depressing, but at least I saved £900 from almost certain doom if I hadn't sold my shares.
Doesn't so much fly as plummet...
Here's the SIPP after week 74
| Weekly Change | |||
| Portfolio cost | £16,776.69 | +£0 | |
| Portfolio sell value (bid price - commission) | £19,594.17 | (+16.8%) | +£87.39 |
| Potential profits | £3,734.54 | +£234.74 | |
| Yr 2 Dividends | £0 | +£0 | |
| Yr 2 Profit from sales | £842.07 | +£0 | |
| Yr 2 Average monthly cash profit | £158.84 | -£7.57 | |
| Yr 2 Avg annual % of current portfolio cost | 11.4% | ||
| Total Dividends | £413.19 | +£0 | |
| Total Profit from sales | £3,191.93 | +£0 | |
| Average monthly cash profit | £206.05 | -£2.83 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 14.7% |
Not bad. Potential profits up nicely by £234, but drops in OPTI:Optibiotix and JLP:Jubilee Platinum ate most of that up. Average monthly performance still way over target 10%, which is good as there's nothing I really want to sell in this portfolio - except WRES:W Resources which was a big mistake.
The trading account looks like this after week 40
| Weekly Change | |||
| Portfolio cost | £1,481.98 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,287.56 | (-13.1%) | -£53.71 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | £61.57 | +£0 | |
| Average monthly cash profit | £6.67 | -£0.17 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 5.4% |
Although an unmitigated disaster based on my expectations, a return of 5.4% isn't bad, if I ever recover the 13.1 paper loss on the portfolio, which I'm sure I will one day...
Urrrrg...
So this week I offloaded one of my two big howlers, with AFG:Aquatic Food biting the dust. My other big howler AFPO:African Potash is currently suspended and I'm not intending to sell as the transaction would cost me £6.38 with the returns not even covering the commission. At some point they will go bust, and my performance will be hit by another big loss, this time of £714. When it happens, I will certainly need to sell something for a similar profit else I risk sinking well below my 10% target for the ISA/shares accounts.
I don't think anything interesting will happen next week. It's a short week with bank holiday, no results or trading statements expected, and I'm quite relieved as there was too much excitement this week. I've decided to leave my bed & ISA order open for JLP:Jubilee Platinum, just to see how long it takes for Hargreaves Lansdown to actually do anything about it. I'm hoping I can rely on them to be sensible and make the transfer when there's a small spread and no volatility, else I'll be somewhat peeved. At current prices that will generate £296 profit from the sale, so should get my average performance back over the magic 10%.
Thursday, 27 April 2017
Amryt Pharma moved into ISA
This morning I got fed up of waiting for Hargreaves Lansdown to process my bed & ISA order, so I loaded £1,500 into my ISA from my current account, sold my share account holding of AMYT:Amryt Pharma and bought the same value in my ISA. As soon as the settlement clears I'll transfer the cash from my share account back to my bank account.
It was a little costly, but tolerable. I made £242.63 profit on the sale, including the buying and selling commission. I sold 6,882 shares at 22.04p making £1,504.84. I bought 6,507 shares at 22.87p costing £1,500.10. So the spread cost me 375 shares, which would be worth £82, but given the price promptly zoomed up to 24p, I gained £73 and still had £4 left over from the sale, so I'm only £5 down on the day, and any profits are now protected from tax.
The best news is that the profit from the sale pushed my average monthly performance up to 9.9% so it won't take much to get back to my 10% target. I know it's a fake addition to profit as I've bought the same shares back again, but those are my accounting rules so it's OK.
My overall AMYT:Amryt Pharma holding is now 33,813 shares, all of which are in my ISA. That's 10.5% of my combined portfolios. After today's 11.4% rise they are making paper profit of £1,769, which is my second best performing share after Star Share IQE:IQE, currently on £2,726 potential profit.
It's not been a great week so far, with OPTI:Optibiotix dropping below 70p and making me wish I had spare cash to buy more, and KIBO:Kibo Mining falling to 4.5p. The £1,167 I lost selling AFG:Aquatic Food on Monday boosted my paper profits by the same amount, but I've lost the £242 from selling the AMYT:Amryt Pharma shares today, and £408 from the rest of the portfolio since then.
Now AFG:Aquatic Food is out of the picture, it's a head-to-head race between OPTI:Optibiotix and KIBO:Kibo Mining for Nemesis Share. At the moment OPTI:Optibiotix is winning, with a paper loss of £1,217 as opposed to KIBO:Kibo Mining losing £1,169. What's most frustrating is both these shares have me locked in and unable to sell because of the promise of free shares in spun-off companies, but neither have said when the qualification date is for the shares. I really hope it's in the past, as I'll be terribly, terribly vexed if day traders get to buy in to hit a record date after I've been holding faithfully all this time. These are both long-term shares anyway, but I have holdings in them both outside my ISA that I want to move in, but can't risk missing the record date as a result. I wish they'd get a move on and tell shareholders what's going on.
Tomorrow sees SXX:Sirius Minerals move from AIM to the main market. I don't know if that's going to help the share price or whether it's already priced in. My recent purchase is 1% up with potential profit of £8 now I've got rid of spread and commission. I really hope there isn't a big sell-off tomorrow else my end of week will be a sorry tale. I have a feeling it's going to be a sorry tale anyway, as OPTI:Optibiotix isn't going to improve until after the launch of the cholesterol product in May, and KIBO:Kibo Mining needs some big news to recover from these lows. That never happens on a Friday, so I fear my portfolio value will take a hit this week.
It was a little costly, but tolerable. I made £242.63 profit on the sale, including the buying and selling commission. I sold 6,882 shares at 22.04p making £1,504.84. I bought 6,507 shares at 22.87p costing £1,500.10. So the spread cost me 375 shares, which would be worth £82, but given the price promptly zoomed up to 24p, I gained £73 and still had £4 left over from the sale, so I'm only £5 down on the day, and any profits are now protected from tax.
The best news is that the profit from the sale pushed my average monthly performance up to 9.9% so it won't take much to get back to my 10% target. I know it's a fake addition to profit as I've bought the same shares back again, but those are my accounting rules so it's OK.
My overall AMYT:Amryt Pharma holding is now 33,813 shares, all of which are in my ISA. That's 10.5% of my combined portfolios. After today's 11.4% rise they are making paper profit of £1,769, which is my second best performing share after Star Share IQE:IQE, currently on £2,726 potential profit.
It's not been a great week so far, with OPTI:Optibiotix dropping below 70p and making me wish I had spare cash to buy more, and KIBO:Kibo Mining falling to 4.5p. The £1,167 I lost selling AFG:Aquatic Food on Monday boosted my paper profits by the same amount, but I've lost the £242 from selling the AMYT:Amryt Pharma shares today, and £408 from the rest of the portfolio since then.
Now AFG:Aquatic Food is out of the picture, it's a head-to-head race between OPTI:Optibiotix and KIBO:Kibo Mining for Nemesis Share. At the moment OPTI:Optibiotix is winning, with a paper loss of £1,217 as opposed to KIBO:Kibo Mining losing £1,169. What's most frustrating is both these shares have me locked in and unable to sell because of the promise of free shares in spun-off companies, but neither have said when the qualification date is for the shares. I really hope it's in the past, as I'll be terribly, terribly vexed if day traders get to buy in to hit a record date after I've been holding faithfully all this time. These are both long-term shares anyway, but I have holdings in them both outside my ISA that I want to move in, but can't risk missing the record date as a result. I wish they'd get a move on and tell shareholders what's going on.
Tomorrow sees SXX:Sirius Minerals move from AIM to the main market. I don't know if that's going to help the share price or whether it's already priced in. My recent purchase is 1% up with potential profit of £8 now I've got rid of spread and commission. I really hope there isn't a big sell-off tomorrow else my end of week will be a sorry tale. I have a feeling it's going to be a sorry tale anyway, as OPTI:Optibiotix isn't going to improve until after the launch of the cholesterol product in May, and KIBO:Kibo Mining needs some big news to recover from these lows. That never happens on a Friday, so I fear my portfolio value will take a hit this week.
Monday, 24 April 2017
Massive loss on Aquatic Food
Over the weekend I took a long hard look at AFG:Aquatic Food. I read and re-read their recent trading update and I tried to be dispassionate. Up till now I've been reluctant to lose £1,100 but after my deliberations, I decided I was in fact rescuing £900.
These were my main reasons from the Q4 trading statement for coming to the conclusion that the risk of AFG:Aquatic Food being a fraud are too high to leave my money invested there
I really, really hope they turn out to be a real company for the sake of those brave enough to tough it out. I cracked, but have learned a very valuable lesson that if something looks too good to be true, there's probably a reason.
The sale hammered my average monthly performance, dropping from £393 a month to £337 and taking the average percentage profit below my 10% target to 9.7%. I'm hoping the profits from bedding shares into my ISA will take me back over my target, if Hargreaves Lansdown ever pull their finger out and process the orders.
I used the liberated cash to get back into SXX:Sirius Minerals as they move from AIM to the main market on Friday. I wanted to get back in earlier but had no cash, and paid the price as shares have risen from about 17p to 25p over the last 4 weeks, following news of the move to the main market. I'm buying for the long term when they join the FTSE 250. I bought 3,949 shares at 25.1875p costing £1,006.60.
The removal of a heavy loss share did help my paper profits, which immediately leapt by the £1,167 I lost from the sale. Unfortunately my portfolio lost £40 today despite lots of blue on most of the shares. Big drops for OPTI:Optibiotix (WHY?!?!?!?!) and KIBO:Kibo Mining wiped out all the little gains.
Tomorrow could be very interesting, with OPTI:Optibiotix giving final results and revealing how well the Go Figure sales are performing. REDS:RedstoneConnect are also posting final results. Any profit could see me able to sell the shares in my trading account and pay that bloody Visa bill...
These were my main reasons from the Q4 trading statement for coming to the conclusion that the risk of AFG:Aquatic Food being a fraud are too high to leave my money invested there
- The update was very downbeat despite the profits being quite good
- There was a remark about having difficulty getting cash out of China to pay the dividend
- There was a statement about holding onto the huge pile of cash as it was prudent in times of uncertainty, but with no threads of hope to shareholders of restoring the value of the dividend or investing in anything
- The director responsible for the IPO has launched other Chinese companies that subsequently de-listed and has now departed the company
- The market cap is a third of the cash pile they have, but still investors are leaving them
- Despite China supposedly taking a stricter stance on companies listing on AIM, de-valuing the shares and then de-listing, it's still happening, with companies like Taihua, Jiasen and MoneySwap all de-listing under dodgy circumstances recently.
I really, really hope they turn out to be a real company for the sake of those brave enough to tough it out. I cracked, but have learned a very valuable lesson that if something looks too good to be true, there's probably a reason.
The sale hammered my average monthly performance, dropping from £393 a month to £337 and taking the average percentage profit below my 10% target to 9.7%. I'm hoping the profits from bedding shares into my ISA will take me back over my target, if Hargreaves Lansdown ever pull their finger out and process the orders.
I used the liberated cash to get back into SXX:Sirius Minerals as they move from AIM to the main market on Friday. I wanted to get back in earlier but had no cash, and paid the price as shares have risen from about 17p to 25p over the last 4 weeks, following news of the move to the main market. I'm buying for the long term when they join the FTSE 250. I bought 3,949 shares at 25.1875p costing £1,006.60.
The removal of a heavy loss share did help my paper profits, which immediately leapt by the £1,167 I lost from the sale. Unfortunately my portfolio lost £40 today despite lots of blue on most of the shares. Big drops for OPTI:Optibiotix (WHY?!?!?!?!) and KIBO:Kibo Mining wiped out all the little gains.
Tomorrow could be very interesting, with OPTI:Optibiotix giving final results and revealing how well the Go Figure sales are performing. REDS:RedstoneConnect are also posting final results. Any profit could see me able to sell the shares in my trading account and pay that bloody Visa bill...
Friday, 21 April 2017
Week 89 Review - Misery and woe
Last week I wrote "Oh unparalleled joy! The green line crashes spectacularly through the
red. I don't care how long it stays there - I should frame this and put
it on my bedroom wall so I always remember how happy I am right now."
The phrase "I don't care how long it stays there" is the painful one, and clearly bollocks. I did care very deeply, which is why I'm sunk into abject misery today as I look at a portfolio that has lost £2,532 of its value in just 4 trading days. The combined value is now £62,513 so I've also lost the 2 "Woohoo!"s from last week. I'm still £1,291 in the black so it could have been worse, but a lot of my buffer has been used up.
The biggest loser this week was the main reason I was so happy last week. Most of the gains vanished for AMYT:Amryt Pharma as a stampede of profit-taking broke out. This was the first time the price had gone above the reverse takeover price, but the sell-off was extreme and caused a 20% drop in the value of my shares.
The other double-digit loser was IQE:IQE dropping 12%, and as one of my other big holdings costing quite a lot. I rather think this was tree-shake behaviour triggering a whole load of stop-losses set to preserve profits. Interesting that every day this happened, all the forced sales were hoovered up. This demonstrates the danger of stop-losses on a volatile share, although if your timing was good you could get back in 12% cheaper. I bet not many people's timing is that good so I'd rather not risk it.
The other losses were less than 10% but for big shares in my portfolio like OPTI:Optibiotix, KIBO:Kibo Mining and CWR:Ceres Power.
There were no double digit risers to counter the drops. The biggest riser was TLOU:Tlou Energy, and that was only 4%.
I didn't want to see that shape.
The ISA and share accounts look like this
Crushing loss of £2,105 and £1,569 of this was reduction in potential profits. My attempt to bed and ISA AMYT:Amryt Pharma and JLP:Jubilee Platinum failed again as Hargreaves Lansdown didn't process the order. I may have to contact them, as the last thing I want is to leave the order open and find they've executed at a time of volatility that could be very costly. When I do this, the average monthly performance will improve, but I'll take a hit on paper value which could take me into the red.
I guess I could load the money from my bank account into my ISA for AMYT:Amryt Pharma as it's £1,500, then return the money to my account after the 3 day settling period from the sale. I can't do the same with JLP:Jubilee Platinum as the shares are worth £4,000, which would bust my overdraft. I suppose I could extend the overdraft to allow for it, as it's only 3 days. Last year Hargreaves Lansdown were really quick with bedding into the ISA, so I don't understand why they are so rubbish this year.
Boo hoo hoo hoo hoooooo.
The SIPP looks like this after week 73
Nowhere near as bad as the other accounts, but the second week in a row with a decline. Not much else going on.
Worrying - very worrying.
The dreaded trading account looks like this after week 39
Could have been a lot worse, with tiny dips in all shares. No chance of flogging KIBO:Kibo Mining to help pay my Visa bill though. At least 5.5% is a better return than I'd get from a savings account - although with 13 weeks to go before this account has been open a year, this figure is projected rather than real.
There's nothing to like with this graph.
I don't think I can blame the calling of the snap election for much of my losses this week. IQE:IQE rely on exchange rates at the moment, so a strengthening pound is bad for them, but I think the potential growth in revenues will offset the exchange rate issue. The good news is that TW.:Taylor Wimpey came withing a few quid of going into profit. Nearly a year after Brexit the price has almost recovered and are dishing out big dividends.
The drop in AMYT:Amryt Pharma shouldn't have been a surprise really. The drop in OPTI:Optibiotix was a massive surprise. Long term holders with spare cash are overjoyed they can add a load more to their ISAs. Tragically I don't have either the cash or any shares I want to sell, so all I can do is watch.
Most intriguing event this week is the news that AFPO:African Potash have suspended their shares on the NEX Exchange as they have announced their intention to buy out private company Onshore Energy Ltd. How the hell? They have no money - they have to pay the directors salaries in shares! I guess I shouldn't be too bothered. At the moment my shares are utterly worthless so things couldn't get worse. If this causes something interesting to happen then what the hell. The fact that Executive Chair Chris Cleverly is a director and shareholder of Onshore Energy is a bit of a worry though. The news also confirms there will be fundraising to make the purchase and cover existing running costs. I'm unable to be anything other than suspicious of this company and it's directors, so will watch with an air of skeptical cynicism.
Hope next week isn't as horrid as this one...
The phrase "I don't care how long it stays there" is the painful one, and clearly bollocks. I did care very deeply, which is why I'm sunk into abject misery today as I look at a portfolio that has lost £2,532 of its value in just 4 trading days. The combined value is now £62,513 so I've also lost the 2 "Woohoo!"s from last week. I'm still £1,291 in the black so it could have been worse, but a lot of my buffer has been used up.
The biggest loser this week was the main reason I was so happy last week. Most of the gains vanished for AMYT:Amryt Pharma as a stampede of profit-taking broke out. This was the first time the price had gone above the reverse takeover price, but the sell-off was extreme and caused a 20% drop in the value of my shares.
The other double-digit loser was IQE:IQE dropping 12%, and as one of my other big holdings costing quite a lot. I rather think this was tree-shake behaviour triggering a whole load of stop-losses set to preserve profits. Interesting that every day this happened, all the forced sales were hoovered up. This demonstrates the danger of stop-losses on a volatile share, although if your timing was good you could get back in 12% cheaper. I bet not many people's timing is that good so I'd rather not risk it.
The other losses were less than 10% but for big shares in my portfolio like OPTI:Optibiotix, KIBO:Kibo Mining and CWR:Ceres Power.
There were no double digit risers to counter the drops. The biggest riser was TLOU:Tlou Energy, and that was only 4%.
I didn't want to see that shape.
The ISA and share accounts look like this
| Weekly Change | |||
| Portfolio cost | £42,964.02 | +£0 | |
| Portfolio sell value (bid price - commission) | £41,665.86 | (-3%) | -£2,105.19 |
| Potential profits | £4,390.03 | -£1,569.02 | |
| Yr 2 Dividends | £357.10 | +£0 | |
| Yr 2 Profit from sales | £3,314.79 | +£0 | |
| Yr 2 Average monthly cash profit | £426.53 | -£11.85 | |
| Yr 2 Avg annual % of current portfolio cost | 11.9% | ||
| Total Dividends | £1,025.03 | +£0 | |
| Total Profit from sales | £7,155.05 | +£0 | |
| Average monthly cash profit | £393.88 | -£4.48 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 11.0% |
Crushing loss of £2,105 and £1,569 of this was reduction in potential profits. My attempt to bed and ISA AMYT:Amryt Pharma and JLP:Jubilee Platinum failed again as Hargreaves Lansdown didn't process the order. I may have to contact them, as the last thing I want is to leave the order open and find they've executed at a time of volatility that could be very costly. When I do this, the average monthly performance will improve, but I'll take a hit on paper value which could take me into the red.
I guess I could load the money from my bank account into my ISA for AMYT:Amryt Pharma as it's £1,500, then return the money to my account after the 3 day settling period from the sale. I can't do the same with JLP:Jubilee Platinum as the shares are worth £4,000, which would bust my overdraft. I suppose I could extend the overdraft to allow for it, as it's only 3 days. Last year Hargreaves Lansdown were really quick with bedding into the ISA, so I don't understand why they are so rubbish this year.
Boo hoo hoo hoo hoooooo.
The SIPP looks like this after week 73
| Weekly Change | |||
| Portfolio cost | £16,776.69 | +£0 | |
| Portfolio sell value (bid price - commission) | £19,506.78 | (+16.3%) | -£403.23 |
| Potential profits | £3,499.80 | -£263.43 | |
| Yr 2 Dividends | £0 | +£0 | |
| Yr 2 Profit from sales | £842.07 | +£0 | |
| Yr 2 Average monthly cash profit | £166.41 | -£8.32 | |
| Yr 2 Avg annual % of current portfolio cost | 11.9% | ||
| Total Dividends | £413.19 | +£0 | |
| Total Profit from sales | £3,191.93 | +£0 | |
| Average monthly cash profit | £208.88 | -£2.90 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 14.9% |
Nowhere near as bad as the other accounts, but the second week in a row with a decline. Not much else going on.
The dreaded trading account looks like this after week 39
| Weekly Change | |||
| Portfolio cost | £1,481.98 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,341.27 | (-9.5%) | -£24.16 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | £61.57 | +£0 | |
| Average monthly cash profit | £6.84 | -£0.18 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 5.5% |
Could have been a lot worse, with tiny dips in all shares. No chance of flogging KIBO:Kibo Mining to help pay my Visa bill though. At least 5.5% is a better return than I'd get from a savings account - although with 13 weeks to go before this account has been open a year, this figure is projected rather than real.
There's nothing to like with this graph.
I don't think I can blame the calling of the snap election for much of my losses this week. IQE:IQE rely on exchange rates at the moment, so a strengthening pound is bad for them, but I think the potential growth in revenues will offset the exchange rate issue. The good news is that TW.:Taylor Wimpey came withing a few quid of going into profit. Nearly a year after Brexit the price has almost recovered and are dishing out big dividends.
The drop in AMYT:Amryt Pharma shouldn't have been a surprise really. The drop in OPTI:Optibiotix was a massive surprise. Long term holders with spare cash are overjoyed they can add a load more to their ISAs. Tragically I don't have either the cash or any shares I want to sell, so all I can do is watch.
Most intriguing event this week is the news that AFPO:African Potash have suspended their shares on the NEX Exchange as they have announced their intention to buy out private company Onshore Energy Ltd. How the hell? They have no money - they have to pay the directors salaries in shares! I guess I shouldn't be too bothered. At the moment my shares are utterly worthless so things couldn't get worse. If this causes something interesting to happen then what the hell. The fact that Executive Chair Chris Cleverly is a director and shareholder of Onshore Energy is a bit of a worry though. The news also confirms there will be fundraising to make the purchase and cover existing running costs. I'm unable to be anything other than suspicious of this company and it's directors, so will watch with an air of skeptical cynicism.
Hope next week isn't as horrid as this one...
Thursday, 13 April 2017
Week 88 Review - Fantastic week
Week 88 has been absolutely brilliant. The brilliance was all thanks to AMYT:Amryt Pharma which single-handedly lifted my ISA and Share portfolios into the black for the first time ever yesterday. Overall the total combined portfolios rose by £1,330 to go £3,823 in the black with a total value of £65,046.48 earning 2 "Woohoo!"s for passing £64K and £65K.
It's a real gap!
There was only one double-digit loser this week, and very disappointingly it was SBTX:SkinBioTherapeutics, dropping 20% and below the price I paid for it resulting in a loss of £72. I really thought this would stick at last week's 16p, but it wasn't to be. Never mind eh.
Not many big risers this week either, but a real surprise was RDT:Rosslyn Data climbing 16% in value today. The share price climbed 33% but that only resulted in a 16% reduction in my losses. These are still 56% down on when I bought them.
Star Share this week was mentioned above. AMYT:Amryt Pharma only climbed 4p but that was 34% and added £1,360 to my portfolio value. I shudder to think what will happen if this reaches the broker targets of 88p this year. Highly unlikely, but it would be worth £21,142. Yummy!
The ISA and share accounts look like this
A staggering £1,876 increase in profits, but some deepening losses meant net gain was £1,577. As mentioned above, nearly all this was thanks to AMYT:Amryt Pharma. I tried to bed my JLP:Jubilee Platinum and AMYT:Amryt Pharma shares into my ISA, but for some reason both days I tried it, Hargreaves Lansdown didn't process the order so I cancelled at the end of the day, not wanting to risk it being done on a volatile market day. I'm tempted to just sell AMYT:Amryt Pharma next week and wait the 3 days to transfer the money to my ISA to re-buy, as I suspect there will be a profit-taking dip. But will there??
I've been looking forward to this graph for a long time
Oh unparalleled joy! The green line crashes spectacularly through the red. I don't care how long it stays there - I should frame this and put it on my bedroom wall so I always remember how happy I am right now.
Here's the SIPP after week 72
Most of the losses were IQE:IQE taking an 8% dip, and ARL:Atlantis Resources slipping lower.
Hmm - just a little wobble...
The trading account looks like this after week 38
I hoped to sell KIBO:Kibo Mining this week so I could retrieve the £500 I lent this account and pay off some of my Visa bill, but the hoped-for news didn't materialise so I'll have to wait a bit longer. It was pay day today, so I still paid off the £500 and have a few weeks wiggle room before I need it back.
Nope - that wasn't supposed to happen!
Right - it's Easter now so I'm going to the pub to celebrate one of the best weeks investing ever. I guess "ever" is only 18 months, but it's the happiest I've felt when writing this review.
Another short week next week. Not sure if there's anything particular expected, so we'll just see how things go on Tuesday.
There was only one double-digit loser this week, and very disappointingly it was SBTX:SkinBioTherapeutics, dropping 20% and below the price I paid for it resulting in a loss of £72. I really thought this would stick at last week's 16p, but it wasn't to be. Never mind eh.
Not many big risers this week either, but a real surprise was RDT:Rosslyn Data climbing 16% in value today. The share price climbed 33% but that only resulted in a 16% reduction in my losses. These are still 56% down on when I bought them.
Star Share this week was mentioned above. AMYT:Amryt Pharma only climbed 4p but that was 34% and added £1,360 to my portfolio value. I shudder to think what will happen if this reaches the broker targets of 88p this year. Highly unlikely, but it would be worth £21,142. Yummy!
The ISA and share accounts look like this
| Weekly Change | |||
| Portfolio cost | £42,964.02 | +£0 | |
| Portfolio sell value (bid price - commission) | £43,771.05 | (+1.9%) | +£1,577.75 |
| Potential profits | £5,959.05 | +£1,876.63 | |
| Yr 2 Dividends | £357.10 | +£0 | |
| Yr 2 Profit from sales | £3,314.79 | +£0 | |
| Yr 2 Average monthly cash profit | £438.38 | -£12.99 | |
| Yr 2 Avg annual % of current portfolio cost | 12.2% | ||
| Total Dividends | £1,025.03 | +£0 | |
| Total Profit from sales | £7,155.05 | +£0 | |
| Average monthly cash profit | £398.36 | -£4.76 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 11.1% |
A staggering £1,876 increase in profits, but some deepening losses meant net gain was £1,577. As mentioned above, nearly all this was thanks to AMYT:Amryt Pharma. I tried to bed my JLP:Jubilee Platinum and AMYT:Amryt Pharma shares into my ISA, but for some reason both days I tried it, Hargreaves Lansdown didn't process the order so I cancelled at the end of the day, not wanting to risk it being done on a volatile market day. I'm tempted to just sell AMYT:Amryt Pharma next week and wait the 3 days to transfer the money to my ISA to re-buy, as I suspect there will be a profit-taking dip. But will there??
I've been looking forward to this graph for a long time
Oh unparalleled joy! The green line crashes spectacularly through the red. I don't care how long it stays there - I should frame this and put it on my bedroom wall so I always remember how happy I am right now.
Here's the SIPP after week 72
| Weekly Change | ||||||||||||||||
| Portfolio cost | £16,776.69 | +£0 | ||||||||||||||
| Portfolio sell value (bid price - commission) | £19,910.01 | (+18.7%) | -£227.99 | |||||||||||||
| Potential profits | £3,763.23 | -£187.07 | ||||||||||||||
| Yr 2 Dividends | £0 | +£0 | ||||||||||||||
| Yr 2 Profit from sales | £842.07 | +£0 | ||||||||||||||
| Yr 2 Average monthly cash profit | £174.73 | -£10.94 | ||||||||||||||
| Yr 2 Avg annual % of current portfolio cost | 12.5% | |||||||||||||||
| Total Dividends | £413.19 | +£0 | ||||||||||||||
| Total Profit from sales | £3,191.93 | +£0 | ||||||||||||||
| Average monthly cash profit | £211.78 | -£3.45 | ||||||||||||||
| (Sold stocks profit + Dividends - Fees / Months) | ||||||||||||||||
| Avg annual % of current portfolio cost | 15.1% |
Most of the losses were IQE:IQE taking an 8% dip, and ARL:Atlantis Resources slipping lower.
Hmm - just a little wobble...
The trading account looks like this after week 38
| Weekly Change | |||
| Portfolio cost | £1,481.98 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,365.43 | (-7.9%) | -£19.60 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | £61.57 | +£0 | |
| Average monthly cash profit | £7.02 | -£0.19 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 5.7% |
I hoped to sell KIBO:Kibo Mining this week so I could retrieve the £500 I lent this account and pay off some of my Visa bill, but the hoped-for news didn't materialise so I'll have to wait a bit longer. It was pay day today, so I still paid off the £500 and have a few weeks wiggle room before I need it back.
Right - it's Easter now so I'm going to the pub to celebrate one of the best weeks investing ever. I guess "ever" is only 18 months, but it's the happiest I've felt when writing this review.
Another short week next week. Not sure if there's anything particular expected, so we'll just see how things go on Tuesday.
Wednesday, 12 April 2017
Amryt soars to put ISA and Share accounts in the black
For the first time since I opened a share account in August 2015, the combined ISA and Share accounts are in paper profit.
They have been getting closer all week, but a 14.1% rise in AMYT:Amryt Pharma today caused the paper profits in that share alone to increase by a staggering £1,360. This obliterated all today's small losses throughout the rest of the shares and leaves the combined ISA and Share portfolios up by £1,657 this week and £887 in the black.
The effect on the overall combined portfolios is an increase of £1,470 as the SIPP has dropped a bit, leaving them £3,964 in the black with a value of £65,186. That's two "Woohoo!"s.
Unfortunately tomorrow is a virtual Friday, and we all know what happens on Fridays. Can this last to the end of the week? Can my snapshot graph show the green line crossing the red tomorrow? Pleeeease...
Nearly everything else did rubbish today, with little drops all over the place.
TND:Tandem Group gave an ok set of final results, but they reversed the recent rises and there was a 3.6% drop. The dividend has increased, so I'll keep holding these as I think 8.4 is unfairly low for a P/E ratio so there's room to rise.
Interesting activity at RDT:Rosslyn Data, with an increase of 3.9% on just 3 hefty trades. This is still down by 67% so it would take something fairly spectacular to recover my losses, but with only 75m shares in issue it could move quite quick if anything good happens.
Rather devastating that SBTX:SkinBioTherapeutics dropped below my purchase price today and to £91 paper loss. I really thought this would keep the momentum up and stick around the 16p mark for a while, but nope, I could have bought cheaper if I'd have hung on. OPTI:Optibiotix also dropped again today and is back into loss. KIBO:Kibo Mining, JLP:Jubileee Platinum and IQE:IQE all trickled lower today too.
So, lets keep everything crossed that AMYT:Amryt Pharma stays where it is tomorrow, and the others get back today's losses so we can end the week on an ultra-high for Easter.
They have been getting closer all week, but a 14.1% rise in AMYT:Amryt Pharma today caused the paper profits in that share alone to increase by a staggering £1,360. This obliterated all today's small losses throughout the rest of the shares and leaves the combined ISA and Share portfolios up by £1,657 this week and £887 in the black.
The effect on the overall combined portfolios is an increase of £1,470 as the SIPP has dropped a bit, leaving them £3,964 in the black with a value of £65,186. That's two "Woohoo!"s.
Unfortunately tomorrow is a virtual Friday, and we all know what happens on Fridays. Can this last to the end of the week? Can my snapshot graph show the green line crossing the red tomorrow? Pleeeease...
Nearly everything else did rubbish today, with little drops all over the place.
TND:Tandem Group gave an ok set of final results, but they reversed the recent rises and there was a 3.6% drop. The dividend has increased, so I'll keep holding these as I think 8.4 is unfairly low for a P/E ratio so there's room to rise.
Interesting activity at RDT:Rosslyn Data, with an increase of 3.9% on just 3 hefty trades. This is still down by 67% so it would take something fairly spectacular to recover my losses, but with only 75m shares in issue it could move quite quick if anything good happens.
Rather devastating that SBTX:SkinBioTherapeutics dropped below my purchase price today and to £91 paper loss. I really thought this would keep the momentum up and stick around the 16p mark for a while, but nope, I could have bought cheaper if I'd have hung on. OPTI:Optibiotix also dropped again today and is back into loss. KIBO:Kibo Mining, JLP:Jubileee Platinum and IQE:IQE all trickled lower today too.
So, lets keep everything crossed that AMYT:Amryt Pharma stays where it is tomorrow, and the others get back today's losses so we can end the week on an ultra-high for Easter.
Subscribe to:
Posts (Atom)